Gamma scintigraphy: An evolving technology in pharmaceutical formulation development - Part 2

Pharmaceutical Science and Technology Today

Volumn 1, Issue 4, 1998, Pages 160-165

  Digenis, George A ^a   Sandefer, Erik P ^a   Page, Richard C ^a   Doll, Walter J ^b  

^a University of Kentucky   (United States)

^b Scintipharma Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 [2 (2 CARBOXYETHYL) 3 [6 (4 METHOXYPHENYL) 5 HEXENYLOXY]PHENOXY]VALERIC ACID; AVITRIPTAN; EUGRADIT S 100; HYDROXYPROPYLMETHYLCELLULOSE PHTHALATE; LEUPRORELIN; SAMARIUM 153; UNCLASSIFIED DRUG;

CLINICAL TRIAL; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG RELEASE; GAMMA SCINTIGRAPHY; HUMAN; NONHUMAN; ORAL DRUG ADMINISTRATION; REVIEW; STOMACH EMPTYING;

EID: 0032127877     PISSN: 14615347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1461-5347(98)00041-8     Document Type: Review

References (25)

1. 1 Griffiths, R., Lee, R.M. and Taylor, D.C. (1977) in Cimetidine: Proceedings of the Second International Symposium on Histamine H-2 Antagonists (Burland, W.L. and Alison-Simkins, M., eds), pp. 38-53, Excerpta Medica
2. 2 Oberle, R.L. and Amidon, G.L. (1987) J. Pharmacokinet. Biopharm. 15, 529-544
3. 3 Veng Pedersen, P. and Miller, R. (1980) J. Pharm. Sci. 69, 394-398
4. 4 Roberts, C.J.C. (1984) Clin. Pharmacokinet. 9, 211-227
5. 5 Marathe, P.H., Greene, D.S. and Barbhaiya, R.H. (1997) Drug Metab. Dispos. 25, 881-888
6. 6 Marathe, P.H. et al. (1997) Biopharm. Drug Dispos. 15, 153-157
7. 7 Marathe, P.H. et al. (1998) J. Pharmacokinet. Biopharm. (in press)
8. 8 Houghton, L.A. et al. (1992) Aliment. Pharmacol.Ther. 6, 685-691
9. 9 Williams, M.F. et al. (1992) Pharm. Res. 9, 1190-1198
10. 10 Barr, W.H. et al. (1994) Clin. Pharmacol.Ther. 56, 279-285
11. 11 Chan, K.K. et al. (1994) Pharm. Res. 11, 432-437
12. 12 Kimura, T. et al. (1994) Biol. Pharm. Bull. 17, 327-333]
13. 13 Read, N.W. et al. (1983) Gastroenterology 84, 1568-1572
14. 14 Sandefer, E.P. et al. (1997) Pharm. Res. 14, S-655
15. 15 Schuster, O. et al. (1984) in Pathophysiologie und Therapie des gestörten Natrium- und Wasserhaushaltes (Workshop Diuretika '84, Bad Nauheim, April 1984) (Graul, E.H. and Loew, D., eds), pp. 128-137
16. 16 Staib, A.H. et al. (1986) Eur. J. Clin. Pharmacol. 30, 691-697
17. 17 Staib, A.H. et al. (1989) Am. J. Med. 87, 66s-69s
18. 18 Harder, S. et al. (1990) Br J. Clin. Pharmacol. 30, 35-39
19. 19 Fuhr, U. et al. (1994) Br. J. Clin. Pharmacol. 38, 83-86
20. 20 Bode, H. et al. (1996) Eur. J. Clin. Pharmacol. 50, 195-201
21. 21 Hugemann, B. and Schuster, O. (1982) German Patent DE 2928477 C3 (A 61 K 9/00)
22. 22 Casper, R.A. et al. (1992) US Patent 5167626 and 5170801
23. 23 Parr, A.F. et al. (1997) Pharm. Res. 14, S-654
24. 24 Doll, W. J. et al. (1997) Pharm. Res. 14, S-654
25. 25 Basilisco, G. and Phillips, S.E (1993) in An Illustrated Guide to Gastrointestinal Motility (Kumar, D. and Wingate, D., eds), pp. 410-426, Churchill